Analysis Of Income And Expense [Abstract]

BioPorto - Filing #5888346

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue
36,243,000 DKK
30,958,000 DKK
Material income and expense [abstract]
Research and development expense
33,533,000 DKK
25,446,000 DKK
Sales and marketing expense
30,202,000 DKK
18,871,000 DKK
Miscellaneous other comprehensive income [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations and hedges of net investments in foreign operations [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations and hedges of net investments in foreign operations
1,277,000 DKK
459,000 DKK
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
69,520,000 DKK
55,869,000 DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.